You are in: eMedicine Specialties > Obstetrics and Gynecology > Infections Fitz-Hugh-Curtis SyndromeArticle Last Updated: Aug 28, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Michael M Frumovitz, MD, Fellow, Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center Michael M Frumovitz is a member of the following medical societies: American College of Obstetricians and Gynecologists Coauthor(s): Charles J Ascher-Walsh, MD, Clinical Assistant Professor, Department of Obstetrics and Gynecology, New York-Presbyterian Medical Center, Columbia University Editors: Gerard S Letterie, DO, Associate Clinical Professor, Medical Director of In-vitro Fertilization Lab, Department of Obstetrics and Gynecology, Virginia Mason Medical Center, University of Washington; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; A David Barnes, MD, PhD, MPH, FACOG, Consulting Staff, Department of Obstetrics and Gynecology, Mammoth Hospital, Mammoth Lakes, California, Pioneer Valley Hospital, Salt Lake City, Utah, Warren General Hospital, Warren, Pennsylvania and Mountain West Hospital, Tooele, Utah; Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Assumption Community Hospital; Lee P Shulman, MD, Professor of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University; Chief, Division of Reproductive Genetics, Department of Obstetrics and Gynecology, Prentice Women's Hospital, Northwestern Memorial Hospital Author and Editor Disclosure Synonyms and related keywords: Fitz-Hugh-Curtis syndrome, FHC syndrome, Fitz-Hugh and Curtis syndrome, infectious perihepatitis, liver infection, pelvic infection, pelvic inflammation, diaphragm inflammation, acute salpingitis, pelvic inflammatory disease, PID, gonorrhea, chlamydia, Neisseria gonorrhoeae, N gonorrhoeae, Chlamydia trachomatis, C trachomatis INTRODUCTIONBackgroundOriginally described in 1920, Fitz-Hugh-Curtis (FHC) syndrome (formally known as Fitz-Hugh and Curtis syndrome) consists of right upper quadrant pain resulting from ascending pelvic infection and inflammation of the liver capsule or diaphragm. Although it is typically associated with acute salpingitis, it can exist without signs of acute pelvic inflammatory disease (PID). In that respect, FHC syndrome can mimic other abdominal emergencies and is often a diagnosis of exclusion. PathophysiologyFHC is an extrapelvic manifestation of PID. It is associated with right upper quadrant pain that likely results from inflammation of the liver capsule and diaphragm. Previously, Neisseria gonorrhoeae was thought to be the main causative agent. However, recent studies have shown that cases of FHC due to Chlamydia trachomatis infection outnumber those due to N gonorrhoeae infection by almost 5 to 1. The spread of bacteria from the pelvis to the liver capsule likely results from the circulation of abdominal fluid over the right paracolic gutter to the subphrenic space and hepatic surface. However, lymphatic and hematogenous spread have not been excluded, and these probably play a role in the dissemination of the disease. FrequencyInternationalFHC syndrome occurs in 15-30% of women with PID. Sex
Age
CLINICALHistoryFitz-Hugh-Curtis (FHC) syndrome consists of 2 phases, termed acute and chronic.
PhysicalWithout a diagnosis of PID, FHC is most often a diagnosis of exclusion.
CausesFHC is caused by infection with C trachomatis or N gonorrhoeae. DIFFERENTIALSAbdominal Trauma, Blunt Adrenal Carcinoma Appendicitis Cholecystitis Cholelithiasis Hepatitis, Viral Nephrolithiasis Pancreatitis, Acute Pancreatitis, Chronic Peptic Ulcer Disease Pneumonia, Bacterial Pneumonia, Fungal Pneumonia, Viral Pulmonary Embolism
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Ceftriaxone (Rocephin) |
|---|---|
| Description | Single-dose therapy. Third-generation cephalosporin with broad-spectrum, gram-negative activity; lower efficacy against gram-positive organisms; higher efficacy against resistant organisms. Arrests bacterial growth by binding to one or more penicillin-binding proteins. |
| Adult Dose | 250 mg IV/IM once |
| Pediatric Dose | 250 mg IV/IM once |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid may increase levels; coadministration with ethacrynic acid, furosemide, and aminoglycosides may increase nephrotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in renal impairment; caution in breastfeeding and penicillin allergy |
| Drug Name | Doxycycline (Doryx, Vibramycin) |
|---|---|
| Description | Broad-spectrum antibiotic. Inhibits protein synthesis and thus bacterial growth by binding to 30S and possibly 50S ribosomal subunits of susceptible bacteria. |
| Adult Dose | 100 mg PO bid for 14 d |
| Pediatric Dose | <100 lb: 2 mg/lb PO divided bid for 14 d >100 lb: Administer as in adults |
| Contraindications | Documented hypersensitivity; severe hepatic dysfunction |
| Interactions | Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy |
| Pregnancy | D - Unsafe in pregnancy |
| Precautions | Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last half of pregnancy through 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines |
Includes antibiotics used to treat the common causes of PID. Regimen includes both ofloxacin and metronidazole (Flagyl)
| Drug Name | Ofloxacin (Floxin) |
|---|---|
| Description | Broad-spectrum antibiotic. Penetrates prostate well and is effective against N gonorrhoeae and C trachomatis. A derivative of pyridine carboxylic acid with broad-spectrum bactericidal effect. |
| Adult Dose | 400 mg PO bid for 14 d |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; ciprofloxacin reduces therapeutic effects of phenytoin; probenecid may increase ciprofloxacin serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT) |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | In prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy |
| Drug Name | Metronidazole (Flagyl) |
|---|---|
| Description | In prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy |
| Adult Dose | 500 mg PO bid for 14 d |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | May increase toxicity of anticoagulants, lithium, and phenytoin; cimetidine may increase toxicity; disulfiramlike reaction may occur with orally ingested ethanol |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in hepatic disease; monitor for seizures and development of peripheral neuropathy |
Includes antibiotics used to treat the common causes of PID. This regimen includes both cefotetan and doxycycline.
| Drug Name | Cefotetan (Cefotan) |
|---|---|
| Description | Wide range of aerobic and anaerobic gram-positive and gram-negative organisms. No activity against chlamydial species |
| Adult Dose | 2 g IV q12h |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Consumption of alcohol within 72 h may produce disulfiramlike reactions; may increase hypoprothrombinemic effects of anticoagulants; coadministration with potent diuretics (eg, loop diuretics) or aminoglycosides may increase nephrotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Reduce dosage by half if CrCl <10-30 mL/min and by one quarter if <10 mL/min; bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged or repeated therapy |
| Drug Name | Doxycycline (Doryx, Vibramycin) |
|---|---|
| Description | Broad-spectrum antibiotic. Inhibits protein synthesis and thus bacterial growth by binding to 30S and possibly 50S ribosomal subunits of susceptible bacteria. |
| Adult Dose | 100 mg PO/IV q12h |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity; severe hepatic dysfunction |
| Interactions | Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy |
| Pregnancy | D - Unsafe in pregnancy |
| Precautions | Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last half of pregnancy through 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines |
Includes antibiotics to treat the common causes of PID. This regimen includes both clindamycin and gentamicin.
| Drug Name | Clindamycin (Cleocin) |
|---|---|
| Description | Broad-spectrum antibiotic. Lincosamide for treatment of serious skin and soft-tissue staphylococcal infections. Also effective against aerobic and anaerobic streptococci (except enterococci). Inhibits bacterial growth, possibly by blocking dissociation of peptidyl t-RNA from ribosomes, causing RNA-dependent protein synthesis to arrest. |
| Adult Dose | 900 mg IV q8h |
| Pediatric Dose | 20-40 mg/kg/d IV divided tid/qid |
| Contraindications | Documented hypersensitivity; regional enteritis, ulcerative colitis, hepatic impairment, antibiotic-associated colitis |
| Interactions | Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis by allowing overgrowth of Clostridium difficile |
| Drug Name | Gentamicin (Gentacidin, Garamycin) |
|---|---|
| Description | Good aerobic coverage. Aminoglycoside antibiotic for gram-negative coverage. Used in combination with both an agent against gram-positive organisms and one that covers anaerobes. Not the DOC. Consider using if penicillins or other less toxic drugs are contraindicated, when clinically indicated, and in mixed infections caused by susceptible staphylococci and gram-negative organisms. |
| Adult Dose | 2 mg/kg loading dose IV, then 1.5 mg/kg q8h |
| Pediatric Dose | 6-7.5 mg/kg/d (2-2.5 mg/kg q8h) IV |
| Contraindications | Documented hypersensitivity; renal insufficiency not on dialysis |
| Interactions | Coadministration with other aminoglycosides, cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; aminoglycosides enhance effects of neuromuscular-blocking agents, thus, prolonged respiratory depression may occur; coadministration with loop diuretics may increase auditory toxicity of aminoglycosides; possible irreversible hearing loss of varying degrees may occur (monitor regularly) |
| Pregnancy | D - Unsafe in pregnancy |
| Precautions | Narrow therapeutic index (not intended for long-term therapy); caution in renal failure (not on dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission; adjust dose in renal impairment |
Pain control is essential to quality patient care. Analgesics ensure patient comfort and have sedating properties, which are beneficial for patients who experience pain.
| Drug Name | Acetaminophen and codeine (Tylenol #3) |
|---|---|
| Description | Indicated for the treatment of mild to moderate pain. |
| Adult Dose | 30-60 mg/dose based on codeine content PO q4-6h or 1-2 tab q4h; not to exceed 4 g/d of acetaminophen |
| Pediatric Dose | 0.5-1 mg/kg/dose based on codeine content PO q4-6h; 10-15 mg/kg/dose based on acetaminophen content; not to exceed 2.6 g/d of acetaminophen |
| Contraindications | Documented hypersensitivity |
| Interactions | Toxicity increases with CNS depressants or tricyclic antidepressants |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Caution in patients dependent on opiates because this substitution may result in acute opiate-withdrawal symptoms; caution in severe renal or hepatic dysfunction |
| Media file 1: "Violin-string" adhesions of chronic Fitz-Hugh-Curtis syndrome. | |
![]() | View Full Size Image | Media type: Photo |
Fitz-Hugh-Curtis Syndrome excerpt
Article Last Updated: Aug 28, 2006